What problem does it solve?
This Skill helps you identify gene dependencies and therapeutic vulnerabilities in cancer by leveraging DepMap dependency scores, drug sensitivity signals, and gene effect profiles.
Core Features & Use Cases
- Cancer-selective dependency discovery: Determine which genes are more essential in specific cancer contexts using Chronos (CRISPR) gene effect scores and cell-line annotations.
- Synthetic lethality and target validation: Compare dependency patterns between biomarker-defined mutant vs. wild-type cell lines to surface synthetic lethal partners and validate oncology targets.
- Drug sensitivity & biomarker analysis: Link PRISM compound sensitivity outcomes with genomic features to prioritize predictive biomarkers for compound response.
- Co-essentiality exploration: Compute correlated dependency profiles to find co-essential genes that may share pathways or complexes.
Quick Start
Ask the Skill to query DepMap for a gene's Chronos dependency scores across cancer cell lines and return the most likely cancer-selective vulnerabilities using cell-line metadata.